CDER appoints deputy director
Executive Summary
Center for Drug Evaluation & Research Acting Deputy Director Douglas Throckmorton is appointed to the post on a permanent basis. Throckmorton became acting deputy director in May 2004 after serving as director of the Division of Cardiovascular & Renal Drug Products since 2002 ("1The Pink Sheet" April 19, 2004, p. 4). He is the founding chair of the Drug Safety Oversight Board and chair of CDER's Research Coordinating Committee...
You may also be interested in...
FDA Cardio-Renal Head Throckmorton Moves Up To Acting Deputy Of CDER
FDA Cardio-Renal Drug Products Division Director Douglas Throckmorton, MD, is moving up to the position of acting deputy director of CDER, effective May 3
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.